Description
Detect SARS-CoV-2 antigens swiftly with COVID-19 Antigen Rapid Test Device. Qualitative in vitro assay for nasal samples within 6 days of symptoms. Authorized for Point of Care settings.
COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care settings.
Brands: Rapid Response, Fastep, BD, Artron, SD Bioscience, Boson and Lumos.
Additional brands are available upon request.
$10.00
Detect SARS-CoV-2 antigens swiftly with COVID-19 Antigen Rapid Test Device. Qualitative in vitro assay for nasal samples within 6 days of symptoms. Authorized for Point of Care settings.
Detect SARS-CoV-2 antigens swiftly with COVID-19 Antigen Rapid Test Device. Qualitative in vitro assay for nasal samples within 6 days of symptoms. Authorized for Point of Care settings.